Commodore Capital’s Sagimet Biosciences SGMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.2M Buy
+2,757,742
New +$25.3M 2.11% 15

Other funds holding SGMT

Commodore Capital's SGMT Position: Q3 2026 in Review

Commodore Capital opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 2,757,742 shares worth $27.2M. The stake represents 2.11% of the portfolio and ranks #15 among its holdings.

147 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

  • Commodore Capital held 2,757,742 shares of Sagimet Biosciences worth $27.2M as of Q3 2026.
  • Sagimet Biosciences was a new Commodore Capital position in Q3 2026.
  • Sagimet Biosciences made up 2.11% of Commodore Capital's portfolio in Q3 2026, its #15 holding.
  • 147 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Commodore Capital's 13F filing for Q3 2026, filed 16 Nov 2026.